Matches in SemOpenAlex for { <https://semopenalex.org/work/W3195737627> ?p ?o ?g. }
- W3195737627 abstract "Background: The prediction of intravenous immunoglobulin (IVIG) resistance and cardiovascular complications are critically clinical issues in Kawasaki disease (KD). This prospective study firstly aimed to determine the predictive ability of the systemic immune inflammation index (SII) for IVIG resistance and cardiovascular complications and compare the prognostic accuracy of SII with that of neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR). Methods: Patients with KD were divided into different groups according to the presence of IVIG resistance or cardiovascular complications (coronary artery lesions, valve regurgitation, myocarditis, pericardial effusion, and Kawasaki disease shock syndrome [KDSS]). The clinical and laboratory parameters were compared. Further analysis stratified by platelet level was performed. Multivariate logistic regression analysis was used to identify predictors for IVIG resistance and cardiovascular complications. The receiver operating characteristic (ROC) curve was applied to assess and compare the ability of SII, NLR, and PLR for predicting IVIG resistance and cardiovascular complications. Results: SII was significantly higher in KD patients with IVIG-resistance, myocarditis, valve regurgitation, and KDSS. It was identified as an independent risk factor for IVIG resistance, myocarditis, and valve regurgitation. For KD patients with thrombocytopenia, there were no significant differences in SII between KD patients with IVIG resistance/cardiovascular complications and those without. The best cutoff values of SII for IVIG resistance, myocarditis, valve regurgitation, and KDSS prediction in the whole cohort were 1331.4 × 10 9 , 1368.6 × 10 9 , 1002.4 × 10 9 , and 1485.4 × 10 9 , with a corresponding sensitivity of 0.525, 0.614, 0.754, and 0.670, a specificity of 0.711, 0.723, 0.584, and 0.730, respectively. The predictive value of SII for both IVIG resistance and cardiovascular complications were not superior to that of NLR. Conclusion: Although the parameter of SII may predict IVIG resistance, myocarditis, valve regurgitation, and KDSS in KD as a single parameter, its predictive ability was not good enough and not superior to NLR. SII might not be applicable in patients with KD having thrombocytopenia." @default.
- W3195737627 created "2021-08-30" @default.
- W3195737627 creator A5015979571 @default.
- W3195737627 creator A5016048028 @default.
- W3195737627 creator A5020147975 @default.
- W3195737627 creator A5039351286 @default.
- W3195737627 creator A5040802687 @default.
- W3195737627 creator A5052835780 @default.
- W3195737627 creator A5053275663 @default.
- W3195737627 creator A5057534899 @default.
- W3195737627 creator A5059818603 @default.
- W3195737627 creator A5078084988 @default.
- W3195737627 creator A5082344505 @default.
- W3195737627 creator A5088170430 @default.
- W3195737627 date "2021-08-24" @default.
- W3195737627 modified "2023-09-29" @default.
- W3195737627 title "Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease" @default.
- W3195737627 cites W175876662 @default.
- W3195737627 cites W1969318919 @default.
- W3195737627 cites W1987394367 @default.
- W3195737627 cites W1996854015 @default.
- W3195737627 cites W1999230879 @default.
- W3195737627 cites W2004049493 @default.
- W3195737627 cites W2015480703 @default.
- W3195737627 cites W2018701699 @default.
- W3195737627 cites W2020577123 @default.
- W3195737627 cites W2021054535 @default.
- W3195737627 cites W2024689401 @default.
- W3195737627 cites W2037179126 @default.
- W3195737627 cites W2041755747 @default.
- W3195737627 cites W2071347890 @default.
- W3195737627 cites W2078868120 @default.
- W3195737627 cites W2082225038 @default.
- W3195737627 cites W2086188037 @default.
- W3195737627 cites W2092491495 @default.
- W3195737627 cites W2101099004 @default.
- W3195737627 cites W2101554991 @default.
- W3195737627 cites W2101825249 @default.
- W3195737627 cites W2107934474 @default.
- W3195737627 cites W2119483101 @default.
- W3195737627 cites W2140921081 @default.
- W3195737627 cites W2143411464 @default.
- W3195737627 cites W2152461467 @default.
- W3195737627 cites W2280039285 @default.
- W3195737627 cites W2511159168 @default.
- W3195737627 cites W2543355859 @default.
- W3195737627 cites W2604027935 @default.
- W3195737627 cites W2620418576 @default.
- W3195737627 cites W2737082469 @default.
- W3195737627 cites W2784112501 @default.
- W3195737627 cites W2804054178 @default.
- W3195737627 cites W2917479942 @default.
- W3195737627 cites W2948132055 @default.
- W3195737627 cites W2986267725 @default.
- W3195737627 cites W2999940972 @default.
- W3195737627 cites W3007417196 @default.
- W3195737627 cites W3015673024 @default.
- W3195737627 cites W3028078525 @default.
- W3195737627 cites W3044574533 @default.
- W3195737627 cites W3080607659 @default.
- W3195737627 cites W3088171078 @default.
- W3195737627 cites W3106702350 @default.
- W3195737627 cites W3126059569 @default.
- W3195737627 cites W3128959641 @default.
- W3195737627 cites W4249795011 @default.
- W3195737627 cites W4253491086 @default.
- W3195737627 doi "https://doi.org/10.3389/fcvm.2021.711007" @default.
- W3195737627 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8421732" @default.
- W3195737627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34504878" @default.
- W3195737627 hasPublicationYear "2021" @default.
- W3195737627 type Work @default.
- W3195737627 sameAs 3195737627 @default.
- W3195737627 citedByCount "16" @default.
- W3195737627 countsByYear W31957376272022 @default.
- W3195737627 countsByYear W31957376272023 @default.
- W3195737627 crossrefType "journal-article" @default.
- W3195737627 hasAuthorship W3195737627A5015979571 @default.
- W3195737627 hasAuthorship W3195737627A5016048028 @default.
- W3195737627 hasAuthorship W3195737627A5020147975 @default.
- W3195737627 hasAuthorship W3195737627A5039351286 @default.
- W3195737627 hasAuthorship W3195737627A5040802687 @default.
- W3195737627 hasAuthorship W3195737627A5052835780 @default.
- W3195737627 hasAuthorship W3195737627A5053275663 @default.
- W3195737627 hasAuthorship W3195737627A5057534899 @default.
- W3195737627 hasAuthorship W3195737627A5059818603 @default.
- W3195737627 hasAuthorship W3195737627A5078084988 @default.
- W3195737627 hasAuthorship W3195737627A5082344505 @default.
- W3195737627 hasAuthorship W3195737627A5088170430 @default.
- W3195737627 hasBestOaLocation W31957376271 @default.
- W3195737627 hasConcept C126322002 @default.
- W3195737627 hasConcept C164705383 @default.
- W3195737627 hasConcept C188816634 @default.
- W3195737627 hasConcept C2776820930 @default.
- W3195737627 hasConcept C2780875844 @default.
- W3195737627 hasConcept C2781175549 @default.
- W3195737627 hasConcept C2781423770 @default.
- W3195737627 hasConcept C58471807 @default.
- W3195737627 hasConcept C71924100 @default.
- W3195737627 hasConcept C90924648 @default.
- W3195737627 hasConceptScore W3195737627C126322002 @default.